ArticleDiabetologia2026
Liver fat content is not elevated in people with type 1 diabetes: the Maastricht Study.
Article in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications.Journal of diabetes investigation · 2026Review
- Obesity in Type 1 Diabetes: Moving Beyond the "Lean" Disease Paradigm to Understand Risk, Complications, and Treatment.Current obesity reports · 2026Review
- Body composition rather than liver fat associates with carotid Intima-Media thickness in youth with type 1 diabetes.Diabetes & vascular disease researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aim/hypothesisObesity and poor dietary habits are thought to explain high liver fat content in type 2 diabetes, but they are increasingly common among individuals with type 1 diabetes. Whether people with type 1 diabetes are at an increased risk of liver fat accumulation remains unclear. We aimed to compare liver fat content in people with type 1 diabetes, with type 2 diabetes and without diabetes.
methodsData were derived from The Maastricht Study, a population-based cohort study. We matched people with type 1 diabetes to those with type 2 diabetes and those with normal glucose metabolism (1:2:2 matching) based on BMI, sex, age and educational level. MRI was used to estimate liver fat content. Liver fat data were log-transformed. We performed multiple linear regression analyses to compare the liver fat content between the three groups, adjusted for potential confounders including CVD risk factors, lifestyle, dietary factors, insulin use and estimated glucose disposal rate (eGDR).
resultsWe included 29 individuals with type 1 diabetes, 58 with type 2 diabetes and 58 with normal glucose metabolism. The median liver fat content in type 1 diabetes was lower than in type 2 diabetes (2.1% [IQR 1.1-3.3] vs 4.9% [IQR 2.2-9.6], p=0.001), but did not differ from that in individuals with normal glucose metabolism (2.6% [IQR 1.8-3.8], p=0.064). The difference in liver fat content between the two diabetes groups was independent of BMI, lifestyle factors, CVD risk factors and dietary factors, but attenuated after adjustment for eGDR and insulin treatment. CONCLUSIONS/
interpretationThe liver fat content of individuals with type 1 diabetes was comparable to that of people without diabetes and lower than that in those with type 2 diabetes. This difference was independent of the level of obesity, dietary factors and other potential confounders, but was partially explained by insulin sensitivity and insulin treatment.
Indexed as
Identifiers
41198917What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.